Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Healthcare Capacity topic
No spam. Unsubscribe anytime.
Office of Health Strategy hearing: Gaylord closing arguments stress Connecticut-specific need; critics warn of harm to safety-net providers
Summary
At an OHS hearing over Gaylord's rehabilitation proposal, counsel for Gaylord urged regulators to weigh Connecticut-specific demand rather than national datasets, while speakers warned approval could create excess capacity and shift Medicaid burdens onto nonprofit providers. The presiding officer set a May 4 deadline for filings and kept the record open for seven days of written comment.
Counsel speaking on behalf of Gaylord urged the Office of Health Strategy to ground its approval decision in Connecticut-specific patient needs, saying national data understates demand in the state.
"National data does not capture the needs patient population on the ground," the counsel said during closing arguments, arguing the agency's national-methodology approach ignored key local differences and the potential effect of a Danbury facility on statewide options.
The speaker described Gaylord's campus and services as distinguishing features: "[Gaylord] provides all the therapies that encompass plans to provide on its 440 acre campus" and, the counsel said, many patients receive frequent therapy sessions that exceed the three-hour, five-day-a-week standard used to qualify inpatient rehabilitation services.
Counsel also sought to narrow the scope of intensive care demand at the facility, saying "there are generally only about five patients that get 135 at any given time. They're on ventilators," and that most patients receive therapy sessions and rehabilitative care rather than prolonged ventilator care.
On data and quality measures, counsel questioned whether faster hospital discharges (cited in testimony as a roughly 12-day median) could inflate apparent demand for inpatient rehabilitation by producing higher readmission rates. The speaker contrasted IRF metrics with skilled nursing and home health patterns and said Connecticut's smaller geography makes interfacility transfers and bed flexing a viable response to temporary surges in demand.
Opposing concerns raised in the hearing focused on market effects and charity care. Counsel framed the stakes as "Goliath against the Davids," warning that approving a large new provider could create an overcapacity of beds, undercut nonprofit safety-net providers that carry larger Medicaid and charity-care caseloads, and leave nonprofits "holding the bag" for Medicaid patients. The transcript includes numbers cited for payer mix: the counsel said the applicant takes "7% Medicaid" in contrast with another large provider that transfers a higher share (the speaker referenced a 28% figure for Yale transfers), though the hearing did not present an adjudicated payer-mix chart in the record.
Participants also critiqued prior decisions and the need-methodology used by the agency, noting a previous Danbury application that had been denied, later modified and approved; counsel said the sequence left unresolved methodological questions about how need is calculated and applied and urged regulators not to rely solely on national benchmarks.
There was no formal vote during the session. The presiding officer said they would include a May 4 deadline for supplemental filings in the official order and reminded remote participants that written public comment would be accepted for seven days after the hearing. The presiding officer then adjourned the hearing on the record.
The Office of Health Strategy did not issue an immediate decision; the record remains open for the deadline established by the presiding officer.
